As consumer AI scanning spreads, UK clinicians will increasingly meet a new scenario: a patient arrives with a private full-body scan report and asks, "Is this serious?" You didn't order the scan, may not know the quality of the modality, and have to decide what — if anything — to do with an out-of-context finding. The safe approach is a structured one: establish why the scan was done, assess symptoms and risk, judge the report's quality, map any finding to recognised guidance, avoid reflexive over-investigation, and safety-net clearly. Here's a practical workflow.
Key takeaways
- Start with why the scan was done and what the patient is actually worried about.
- Assess symptoms and risk factors first — the finding means little without clinical context.
- Map any finding to recognised UK follow-up guidance rather than reacting to the report alone.
- Avoid the two opposite errors: ignoring a real finding, and chasing low-value ones.
- Document your reasoning and safety-net clearly — both matter medico-legally.
The scenario you'll increasingly see
A well, asymptomatic patient pays for a private AI scan, receives a report listing one or more findings, and brings it to you for interpretation. The clinical question wasn't theirs or yours to begin with — the scan generated it. Your job is to convert an out-of-context finding into a proportionate, evidence-based plan, without either dismissing the patient or over-investigating them.
A practical workflow
- Establish why the scan was done. Symptom-driven, family-history concern, or general reassurance-seeking? This frames everything that follows.
- Assess symptoms and risk factors. Take a proper history and examine as indicated. A finding in a genuinely asymptomatic, low-risk person carries very different weight from the same finding with symptoms or risk factors.
- Check the modality and report quality. What was the scan, and how good is the report? Protocols vary widely between providers, and many consumer scans aren't to clinical standard.
- Map the finding to recognised guidance. Does it correspond to a recognised follow-up pathway — for example, established guidance on managing a specific incidental finding — or is it non-specific?
- Avoid reflexive over-investigation. Not every reported abnormality needs imaging, bloods or referral. Many incidental findings have conservative, watchful pathways.
- Safety-net clearly. Tell the patient what to look out for and when to return, and make the threshold for review explicit.
- Document the uncertainty. Record your reasoning, what you've actioned and why, and what you've deliberately not actioned.
Worked examples
These illustrate the principle — always check current guidance for the specific finding:
- Thyroid nodule: common and usually benign; management depends on ultrasound characteristics and size against recognised criteria, not on the report's wording alone.
- Renal cyst: frequently a simple, benign finding; categorisation guides whether anything further is needed.
- Liver lesion: many are benign (such as simple cysts or haemangiomas), but characterisation matters; map to recognised guidance.
- "Mild fatty liver": often a lifestyle and risk-factor conversation with appropriate checks, not an urgent imaging cascade.
- Indeterminate lymph node: context-dependent; size, distribution and clinical picture matter more than the label.
- Body-composition findings: typically not pathology at all — useful to say so plainly to avoid unnecessary worry.
The medico-legal balance
There's tension in both directions. Ignoring a genuinely abnormal scan is a clear risk. But pursuing every reported finding with low-value testing exposes patients to harm, drains scarce capacity, and isn't good medicine either. The defensible position is the same one good practice always rewards: assess against symptoms, risk and recognised guidance; act proportionately; and document your reasoning. The presence of a private report doesn't lower the bar for sensible clinical judgement — if anything it raises the need to articulate it.
The NHS spillover
It's worth naming the system issue: private scans are privately paid, but their follow-up frequently lands in the NHS. A scan bought for reassurance can generate publicly funded imaging, referrals and clinic time. That's not a reason to dismiss patients, but it is a reason to be deliberate and evidence-based about what genuinely warrants further NHS investigation.
How a reference tool helps
When a finding lands in front of you, the practical need is fast access to what recognised guidance recommends. Ask iatroX is free and lets you check management of a given incidental finding against UK sources (NICE, CKS, SIGN and the SmPC) at the point of care — supporting a proportionate, documented response, without implying any automated diagnosis. The judgement remains yours; the reference just makes the relevant guidance quick to find.
Frequently asked questions
What should a GP do with a private full-body scan report? Establish why it was done, assess symptoms and risk, check the report quality, map any finding to recognised guidance, act proportionately, safety-net, and document your reasoning — rather than acting on the report in isolation.
Do I have to act on every finding in a private scan? No. Many incidental findings are benign or have conservative pathways. The task is to distinguish findings that map to recognised follow-up from non-specific ones, and to avoid low-value over-investigation.
What are the medico-legal risks? Both ignoring a genuinely abnormal finding and over-investigating benign ones carry risk. The defensible approach is to assess against symptoms, risk and guidance, act proportionately, and clearly document your reasoning and safety-netting.
Does the NHS have to fund follow-up of private scans? Follow-up often does fall to the NHS in practice, which is why proportionate, evidence-based decisions about what genuinely warrants further investigation matter — clinically and for system capacity.